Related Experiment Video
Updated: Jun 3, 2026
Cell-based Flow Cytometry Assay to Measure Cytotoxic Activity
Published on: December 17, 2013
Visualization and quantification of cytotoxicity mediated by antibodies using imaging flow cytometry
Gustavo Helguera1, José A Rodríguez, Rosendo Luria-Pérez
1Division of Surgical Oncology, Department of Surgery, David Geffen School of Medicine, University of California, Los Angeles, USA. ghelguera@ffyb.uba.ar
This study introduces a novel imaging flow cytometry method to directly visualize and quantify antibody-dependent cell-mediated cytotoxicity (ADCC) in cancer cells. This technique offers detailed insights into effector-target cell interactions and cellular changes during ADCC. Keywords: antibody-dependent cell-mediated cytotoxicity, ADCC, imaging flow cytometry, cancer immunotherapy.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Traditional methods for assessing antibody-dependent cell-mediated cytotoxicity (ADCC) involve measuring released compounds or population-wide flow cytometry.
- These conventional approaches lack detailed cellular interaction insights during ADCC events.
Purpose of the Study:
- To develop and validate a new method for direct imaging and quantification of ADCC in cancer cells.
- To provide a comprehensive perspective on effector and target cell interactions during ADCC.
Main Methods:
- Utilized imaging flow cytometry to combine population analysis with single-cell imaging.
- Employed CFSE-labeled Ramos human Burkitt's lymphoma cells and CMTPX-labeled U-937 effector cells with anti-CD20 antibody rituximab as a model system.
Main Results:
- The imaging flow cytometry method allows detailed quantification of morphological changes in effector and target cells.
- Enabled assessment of apoptotic index and physical interactions between cells.
- Demonstrated directional transfer of cytosolic contents from effector to target cells during ADCC.
Conclusions:
- The developed imaging flow cytometry technique offers a novel, comprehensive approach to study ADCC.
- This method can aid in the pre-clinical evaluation of therapeutic antibodies for cancer immunotherapy.
- Provides detailed mechanistic insights into effector-target cell dynamics in ADCC.
